Erector Spina Plane (ESP) Block in Pediatric Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-10

Study Completion Date

2022-07-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, we aimed to evaluate the erector spina plane (ESP) block method that we used in our clinic with ultrasonography in pediatric cases between 1 month and 2 years of age who underwent laparotomy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Transversus Abdominis Plane Block Versus Erector Spina Plane Block

NCT04095325

Intraoperative Pain Control

UNKNOWN NA

Erector Spinae Plane Block for Paediatric Upper Abdominal Surgery

NCT04518215

Paediatric Surgery Analgesia +1 more

COMPLETED NA

Erector Spinae Plane Block for Peroperative Analgesia and Intraabdominal Tissue Oxygenation

NCT03808129

Lower Abdominal Surgery

COMPLETED NA

The Effect of Ultrasound-guided Erector Spinae Block on Postoperative in Patients Undergoing Nephrectomy.

NCT04703634

Nephrectomy

COMPLETED NA

Sacral Erector Spinae Plane Blocks in Pediatric Patients

NCT05415046

Postoperative Pain

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

36 patients who will undergo laparotomy between the ages of 1 month and 2 years in ASA ( American Society of Anesthesiologists) I-II class will be included in the study. patients will be divided into 2 groups. Intraoperative erector spina plane block will be applied to the 1st group (group E) and intraoperative local anesthetic infiltration will be applied to the 2nd group (group L). Postoperative pain will be evaluated with the FLACC (face, legs, activity, crying, consolation) scale.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Postoperative Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group E

Intraoperative Erector spina plane block ( 0.3 ml/kg bupivacaine 0.25% at thoracic level 7 and 0.3 ml/kg bupivacaine 0.25% bupivacaine at thoracic level 11, totaling 0.6 ml/kg of 0.25% bupivacaine) will be performed after the surgery is completed.

Group Type OTHER

Erector spina plane block

Intervention Type OTHER

After the surgery is completed, intraoperative Erector spina plane block will be performed

group L

Intraoperative local infiltration (0.6 ml/kg of 0.25% bupivacaine will be given to the wound lips at the end of the surgery.

Group Type OTHER

local infiltration

Intervention Type OTHER

After the surgery is completed, intraoperative local infiltration will be performed

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Erector spina plane block

After the surgery is completed, intraoperative Erector spina plane block will be performed

Intervention Type OTHER

local infiltration

After the surgery is completed, intraoperative local infiltration will be performed

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1 month and 2 years of age
* ASA (American Society of Anesthesiologists) I-II class
* Patients who underwent nephrectomy, pyeloplasty, adrenal tumor excision with unilateral paramedian incision

Exclusion Criteria

* Patients who underwent laparotomy with a midline incision
* Local infection at the injection site,
* Anatomical anomalies
* Allergies to local anesthetics,
* Coagulopathy,
* Liver, kidney failure patients

Minimum Eligible Age

1 Month

Maximum Eligible Age

2 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No